fentaNYL 1.5 mcg/mL and bupivacaine 0.125% PF in 0.9% recall: Sterility Concern
fentaNYL 1.5 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride / Total Volume = 50 mL, Total fentaNYL 75 mcg/50 mL, 50 mL Syringe, Rx only…
Why was fentaNYL 1.5 mcg/mL and bupivacaine 0.125% PF in 0.9% recalled?
Lack of assurance of sterility:
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot: 17-275165, 17-275166, Exp. 10/1/2023; 17-275217, Exp. 10/2/2023; 17-275715, Exp. 10/9/2023; 17-276035, Exp. 10/16/2023; 17-276112, Exp. 10/17/2023
- Product
- fentaNYL 1.5 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride / Total Volume = 50 mL, Total fentaNYL 75 mcg/50 mL, 50 mL Syringe, Rx only…
- Recalling firm
- Central Admixture Pharmacy Services Inc
- Quantity
- 895 50 mL syringes
- Distribution
- Nationwide in the USA
- Recall date
- October 11, 2023
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)